BTCY Biotricity Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: BTCY

Price (delayed)

$1.25

Market cap

$11.57M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.75

Enterprise value

$33.99M

Highlights
The gross profit has grown by 42% YoY and by 11% from the previous quarter
The revenue rose by 29% year-on-year and by 4.6% since the previous quarter
The equity has shrunk by 79% YoY and by 3.8% QoQ
The company's quick ratio has shrunk by 71% YoY and by 41% QoQ
Sector: Healthcare
Industry: Medical Devices
Peers: OBIO OM

Key stats

What are the main financial stats of BTCY
Market
Shares outstanding
9.26M
Market cap
$11.57M
Enterprise value
$33.99M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
0.97
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.92
Earnings
Revenue
$11.63M
EBIT
-$10.54M
EBITDA
-$9.92M
Free cash flow
-$7.41M
Per share
EPS
-$1.75
Free cash flow per share
-$0.82
Book value per share
-$3.17
Revenue per share
$1.29
TBVPS
$0.61
Balance sheet
Total assets
$5.49M
Total liabilities
$32.21M
Debt
$22.59M
Equity
-$27.76M
Working capital
-$14.69M
Liquidity
Debt to equity
-0.81
Current ratio
0.21
Quick ratio
0.1
Net debt/EBITDA
-2.26
Margins
EBITDA margin
-85.3%
Gross margin
65.5%
Net margin
-125.4%
Operating margin
-68%
Efficiency
Return on assets
-246.5%
Return on equity
N/A
Return on invested capital
-96.1%
Return on capital employed
N/A
Return on sales
-90.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

BTCY stock price

How has the Biotricity stock price performed over time
Intraday
-3.85%
1 week
-3.1%
1 month
-6.02%
1 year
-94.22%
YTD
8.7%
QTD
-15.54%

Financial performance

How have Biotricity's revenue and profit performed over time
Revenue
$11.63M
Gross profit
$7.62M
Operating income
-$7.9M
Net income
-$14.58M
Gross margin
65.5%
Net margin
-125.4%
The operating margin has soared by 61% year-on-year and by 29% since the previous quarter
The operating income has soared by 50% YoY and by 25% QoQ
The net margin has increased by 42% year-on-year and by 14% since the previous quarter
The gross profit has grown by 42% YoY and by 11% from the previous quarter

Growth

What is Biotricity's growth rate over time

Valuation

What is Biotricity stock price valuation
P/E
N/A
P/B
N/A
P/S
0.97
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.92
The company's EPS rose by 26% YoY and by 11% QoQ
The equity has shrunk by 79% YoY and by 3.8% QoQ
BTCY's P/S is 94% lower than its 5-year quarterly average of 16.1 and 54% lower than its last 4 quarters average of 2.1
The revenue rose by 29% year-on-year and by 4.6% since the previous quarter

Efficiency

How efficient is Biotricity business performance
The company's return on sales has surged by 52% YoY and by 20% QoQ
BTCY's ROA is down by 30% YoY but it is up by 6% from the previous quarter
The company's return on invested capital rose by 12% YoY and by 3% QoQ

Dividends

What is BTCY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BTCY.

Financial health

How did Biotricity financials performed over time
The total assets is 83% smaller than the total liabilities
The company's quick ratio has shrunk by 71% YoY and by 41% QoQ
Biotricity's current ratio has plunged by 68% YoY and by 28% from the previous quarter
The debt is 181% greater than the equity
The equity has shrunk by 79% YoY and by 3.8% QoQ
The debt has increased by 29% year-on-year and by 6% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.